Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026
Sponsor: Pfizer
Summary
The purpose of this study is to learn about the management, treatment, healthcare resource utilization (HCRU), and outcomes of individuals with SARS-CoV-2 infection. This is a retrospective secondary analysis of administrative claims data from 2023-2026, therefore there is no enrollment or participation required. The study will describe and evaluate the real-world management, treatment, HCRU, and outcomes of individuals with SARS-CoV-2 infection.
Official title: CURRENT TREATMENT MANAGEMENT AND OUTCOMES OF INPATIENTS WITH SARS-COV-2
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1
Start Date
2026-07-20
Completion Date
2026-10-30
Last Updated
2026-10-28
Healthy Volunteers
No
Conditions
Interventions
Patients with COVID-19
Treatment of Patients with COVID-19 from 2023-2026
Locations (1)
Pfizer New York
New York, New York, United States